|View printer-friendly version|
|June 28, 2007 1:50 p.m.|
|Teva Announces Tentative Approval Of Famciclovir Tablets|
Jerusalem, Israel, June 28, 2007 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Famciclovir Tablets, 125 mg, 250 mg and 500 mg. Final approval of this application is anticipated on August 24, 2007, upon expiry of the mandatory stay of approval associated with patent litigation related to this application.